IMI Members

2012
- Parliament Magazine, 10 May 2012
Public private partnerships key to growth of EU pharma research
- Science-Business eXchange, 10 May 2012
A mind for precompetitive collaboration
- Science-Business eXchange, 19 April 2012
Building tools against autism
- Nature Medicine, 5 April 2012
Europe plans molecular screening center for translational research
- Science-Business eXchange, 29 March 2012
IMI's leadoff hitter
- Nature, 27 March 2012
Chemistry’s web of data expands
- InPharm, 12 March 2012
UCB chief executive to chair IMI
- SCRIP Intelligence, 8 March 2012
Seven pharma fuel €170m EU-wide screening honeypot
- Pharma Times, 8 March 2012
IMI to set up European Lead Factory for new drug opportunities
- Pharma Times, 8 March 2012
UCB chief Doliveux to head IMI
- PharmaNews, 8 March 2012
IMI funds platform to discover new medicines
- PMLiVE, 7 March 2012
Europe's IMI plans compound library and screening centre
- Science Translational Medicines, February 2012
Recalibrating Intellectual Property Rights to Enhance Translational Research Collaborations
- Innovation Excellence, 6 January 2012
Open Innovation, Technology Platforms and a New Business Model- All-in-One Biggie!
2011
- Pharma Times, 20 December 2011
IMI, CDISC hook up for standardised data management
- Bio-IT World, 20 December 2011
CDISC and IMI Sign Standards Agreement
- Scrip Intelligence, 9 December 2011
EU launches €80bn R&D plan to cut red tape, create jobs and boost competitiveness
- Pharmacuetical Market Europe, 6 December 2011
Interview: Michel Goldman, Innovative Medicines Initiative
- TV5Monde, 3 December 2011
Bar de l'Europe
- Pharma Times, 1 December 2011
EFPIA welcomes partnership commitment in Horizon 2020 proposal
- Science Business Publishing
Open Innovation and Public Policy in Europe
- Pharmaceutical Market Europe, December 2011
Interview: Michel Goldman, Innovative Medicines Initiative
- Nature Reviews Drug Discovery, December 2011
Expanding precompetitive space (editorial)
- Public Service Europe, 28 November 2011
Antibiotics and the future of the pharmaceutical industry
- Science Business, 23 November 2011
Commission lures pharma industry back into antibiotics
- Nature, 22 November 2011
Antibiotic resistance marching across Europe
- Parliament Magazine, 21 November 2011
Joint technology initiatives: Maria da Graça Carvalho
- Scrip Intelligence, 18 November 2011
IMI plans "unprecedented" programme for novel antibiotics as drug resistance continues to rise
- InPharm, 17 November 2011
Industry supports bid to revitalise antibiotic research
- Reuters, 17 November 2011
Europe kickstarts R&D fightback against superbugs
- Applied Clinical Trials, 1 November 2011
An Update to Real Innovation
- Parliament Magazine Research Review, November 2011
The best medicine (p. 130)
- European Federation of Neurological Associations (EFNA), Autumn 2011
Innovative Medicines Initiative (IMI): A revolution in the drug development world
- European Voice, 22 September 2011
Pushing at the doors of innovation
- Pharmaceutiques, September 2011
L’Initiative medicaments innovants (IMI)
- Trends, 1 September 2011
L'IMI, l'agence qui dessine la médecine de demain
- BioCentury TV, 31 July 2011
Public + Private Part 2: Turning Great Science into Medicine -- and Jobs
- Nature Reviews Drug Discovery, August 2011
Partnering between pharma peers on the rise
- Scrip Intelligence, 1 August 2011
EU firms targeted in calls for new biomarkers and drug development tools
- BioCentury TV, 24 July 2011
Public + Private: Turning great science into medicine – and Jobs
- Science Business, 22 July 2011
Patients take control of innovation
- Scrip Intelligence, 15 June 2011
EU IMI and US Critical Path avoid duplication
- Science Business, 15 June 2011
EU’s Innovative Medicines Initiative to collaborate with FDA’s Critical Path
- Pharma Times, 15 June 2011
US and EU link faster pharma R&D initiatives
- Projects, June 2011 (Issue 24)
A new wave of innovative drugs projects (pp. 14-16)
- HealthTechWire, 13 May 2011
What is coming next at IMI?
- Projects, May 2011 (Issue 23)
Partners in medical innovation (pp. 48-49)
- BMJ, 10 March 2011
Europe provides €172m for research into innovative medicines
- La Libre Belgique, 9 March 2011
L’union sacrée du secteur pharma
- Science Business, 09 March 2011
Maybe Europe’s pharma sector can save itself